Myeloperoxidase activity and acute coronary syndrome survival: long-term evaluation in the ERICO study

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
FUTURE MEDICINE LTD
Autores
LEOCADIO, Paola Caroline Lacerda
MENTA, Penelope Lacrisio dos Reis
ALVAREZ-LEITE, Jacqueline Isaura
Citação
BIOMARKERS IN MEDICINE, v.12, n.11, p.1219-1229, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aim: We aimed to analyze the influence of myeloperoxidase (MPO) activity on mortality in the Acute Coronary Syndrome Registry Strategy (ERICO) study. Methods: MPO activity levels were evaluated in 342 patients. We performed survival analyses using Kaplan-Meier curves and Cox regression with respective hazard ratios, 95% CI, according to MPO tertiles distribution up to 7 years of follow-up. Results: Higher MPO activity levels were seen in men, smokers, diabetics and those who were taking aspirin. MPO activity levels were neither significant in relation to mortality nor to survival rates up to seven years. Conclusion: We found no relationship between elevated levels of MPO activity post-acute coronary syndrome and mortality up to 7-years of follow-up in the ERICO study.
Palavras-chave
acute coronary syndrome, angina, inflammation, mortality, myeloperoxidase activity, myocardial infarction, oxidative stress
Referências
  1. Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51
  2. Boudjeltia KZ, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/750742
  3. Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003
  4. Chang PY, 2006, CLIN CHIM ACTA, V373, P158, DOI 10.1016/j.cca.2006.05.030
  5. Chapman ALP, 2013, J BIOL CHEM, V288, P6465, DOI 10.1074/jbc.M112.418970
  6. Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081
  7. Garca MF, 2013, J MEMBRANE BIOL, V246, P519, DOI 10.1007/s00232-013-9561-8
  8. Goldmann BU, 2009, FREE RADICAL BIO MED, V47, P79, DOI 10.1016/j.freeradbiomed.2009.04.004
  9. Goulart AC, 2013, CLINICS, V68, P431, DOI 10.6061/clinics/2013(03)RC02
  10. Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
  11. Heslop CL, 2010, J AM COLL CARDIOL, V55, P1102, DOI 10.1016/j.jacc.2009.11.050
  12. Karahocagil MK, 2012, CLIN BIOCHEM, V45, P733, DOI 10.1016/j.clinbiochem.2012.03.017
  13. Klinke A, 2011, BLOOD, V117, P1350, DOI 10.1182/blood-2010-05-284513
  14. Kubala L, 2008, CLIN CHIM ACTA, V394, P59, DOI 10.1016/j.cca.2008.04.001
  15. Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
  16. Lucio ED, 2011, INFLAMM RES, V60, P137, DOI 10.1007/s00011-010-0247-8
  17. Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA
  18. Mocatta TJ, 2007, J AM COLL CARDIOL, V49, P1993, DOI 10.1016/j.jacc.2007.02.040
  19. Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046
  20. Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X
  21. Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549
  22. Prefeitura do Municipio de Sao Paulo, 2004, BUT REG OEST, P1
  23. Ribeiro ALP, 2016, CIRCULATION, V133, P422, DOI 10.1161/CIRCULATIONAHA.114.008727
  24. Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
  25. Rudolph Tanja K, 2008, Proc Am Thorac Soc, V5, P820, DOI 10.1513/pats.200807-063TH
  26. Santos IS, 2015, ARQ BRAS CARDIOL, V105, P53, DOI 10.5935/abc.20150044
  27. Stolic RV, 2014, HEMODIAL INT, V18, P680, DOI 10.1111/hdi.12155
  28. Thygesen K, 2007, EUR HEART J, V28, P2525
  29. Vedanthan R, 2014, CIRC RES, V114, P1959, DOI 10.1161/CIRCRESAHA.114.302782
  30. Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F
  31. Zhang T, 2013, BIOL TRACE ELEM RES, V152, P379, DOI 10.1007/s12011-013-9632-9
  32. Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136
  33. Zhou T, 2006, CLIN CHIM ACTA, V368, P168, DOI 10.1016/j.cca.2005.12.040